I would like to think I have half a brain, so why would any big pharma not want to keep TBG if it was a valuable technology?
Much easier and much more traditional to create a former management buyout after buying and paying for the real value of the company.
(0)
(0)
Decision Diagnostics Corp (DECN) Stock Research Links
-
-
-
-
-
-
-